Cell Based Assays

Check out our 2for1 offer!

There is constant demand to refine this powerful research tool. This conference will present the latest information regarding how to improve the accuracy of this technique - including optimising cellular conditions, developing quantitative technologies and enhancement of biomarkers. Speakers will focus on the ways in which this technique facilitates research in numerous therapeutic areas, notably stem cells and oncology.

Other conference tracks at this event include Cancer & Stem Cells, Cell Culture, Circulating Tumour Cells and Flow Cytometry. Registered delegates will have access to all five meetings ensuring a very cost-effective trip.

Session Sponsors

Keynote Speakers

Hakim Djaballah
Director, Memorial Sloan Kettering Cancer Center

Stephen Minger
Global R&D Leader, Cell Technologies, GE Healthcare

Agenda Topics

Apoptosis Assays
Assays for Phenotypic Changes: Invasion, Migration, Angiogenesis
Case Studies from Biotechnology and Pharmaceutical Companies
Elements of Assay Development: A Nuts-and-Bolts Perspective
High-Content Analysis (HCA) Assays
Instrumentation for Cell-based Assays
Metabolism-monitoring Assays
Morphology Changes as a Readout
Reporter Gene Assays and their Utility for Drug Discovery Projects

Sponsorship and Exhibition Opportunities

Aaron Woodley, Sales & Marketing Manager
a.woodley@selectbiosciences.com
+44 (0)1787 315129

Speakers

Peter Antinozzi, Assistant Professor, Wake Forest University School of Medicine
Nathan Bays, Senior Therapeutic Scientist, Merck and Co Inc
Eric Johnson, Associate Professor, University of Wisconsin
Robert Damoiseaux, Scientific Director, University of California Los Angeles
Robin Ketteler, Group Leader, University College London
Roland Wolkowicz, Associate Professor , San Diego State University
Michel Roberge, Scientific Director, University of British Columbia
Cedric Gaggioli, Senior Post Doctoral Fellow, University of Nice
Anthony Davies, Director, High Content Research Facility, National Center for High Content Screening and Analysis (INCHA)
Aydogan Ozcan, Associate Professor, University Of California Los Angeles
Anne Bang, Director, Sanford Burnham Medical Research Institute
Jeffrey Kelly, Researcher, Promega
Sung Wook Jang, Investigator, National Institutes of Health (NIH)

Corporate Sponsors	Media Sponsors	Official Journal Partner Web Sponsor	Networking

Corporate Sponsors

There is currently no news for this track.